Biopsy Complications
Biopsy Complications - Related Videos
09:01
A Technique for Subcutaneous Abdominal Adipose Tissue Biopsy via a Non-diathermy Method
0 Views •
Cited by 7 •
2017
We standardized an abdominal adipose tissue biopsy using a non-diathermy method performed under local anesthesia. Three cases of excessive post-operation bleeding out of 115 operations (2.61%) occurred.We conclude that an abdominal adipose tissue surgical biopsy using a non-diathermy method can be safely applied to healthy men.
01:24
Healing II: Complications
0 Views •
2026
Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
05:32
Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
0 Views •
Cited by 5 •
2015
Here, we present a protocol for use at the time of transrectal ultrasound guided prostate needle biopsy (TRUS PNB) that is a simple and cost-effective means to reduce infections following the procedure.
07:16
Human Vastus Lateralis Skeletal Muscle Biopsy Using the Weil-Blakesley Conchotome
0 Views •
Cited by 18 •
2016
This video demonstrates the technique of percutaneous muscle biopsy of the human vastus lateralis using the Weil-Blakesley conchotome.
11:22
Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
0 Views •
Cited by 5 •
2013
In order to study the changes of nociceptive intraepidermal nerve fibers (IENFs) in painful neuropathies (PN), we developed protocols that could directly examine three-dimensional morphological changes observed in nociceptive IENFs. Three-dimensional analysis of IENFs has the potential to evaluate the morphological changes of IENF in PN.
FAQs
Bleeding occurs when tissue removal disrupts blood vessels at or near the sampling site. The extent of risk depends partly on the biopsy site, instrument, and route used to obtain tissue. Clinicians consider these variables during planning because bleeding can remain minor or form a hematoma, a localized collection of blood within injured tissue.
Severity varies with the biopsy site, the instrument selected, the route through which tissue is sampled, and individual patient factors. These variables affect the amount of tissue disruption and the possibility of injuring nearby structures. Considering them together helps clinicians anticipate risk rather than treating every biopsy as having the same complication profile.
Tissue injury can produce pain, bleeding, or damage to structures near the sampling area. Contamination can contribute to infection, creating a different problem from mechanical injury alone. Because these pathways are distinct, clinicians assess both the local tissue effects of the procedure and the possibility that contamination has contributed to later symptoms.
These findings may indicate that a complication requires clinical assessment rather than routine observation. Persistent bleeding can signal ongoing vessel disruption, while fever may accompany infection; worsening pain or impaired function can suggest significant tissue effects or injury near an important structure. Recognizing these changes supports timely management while preserving attention to the biopsy result.
Planning should account for the biopsy site, instrument, sampling route, and relevant patient factors before tissue is removed. Clinicians use this assessment to anticipate bleeding, pain, infection, hematoma, or injury to nearby structures while maintaining the procedure's diagnostic purpose. This balance helps support safer diagnostic care instead of focusing on sampling alone.
Informed consent should address the possibility of adverse effects, including pain, bleeding, infection, hematoma, and damage to nearby structures. Patients should also know which changes warrant attention, such as persistent bleeding, fever, worsening pain, or impaired function. Clear discussion prepares patients to recognize concerning outcomes and seek timely clinical management when needed.
Monitoring focuses on symptoms and functional changes that could indicate a complication. Clinicians assess for persistent bleeding, fever, worsening pain, or impaired function, while considering the biopsy site and the procedure's instrument and route. This approach helps distinguish expected minor effects from findings that may require timely management and protects the diagnostic value of the procedure.